Interleukin-15 is not required for the induction or maintenance of orally induced peripheral tolerance

Immunology

Volumn 113, Issue 3, 2004, Pages 304-309

  Millington, Owain R ^a   Wei, Xiao Qing ^a   Garside, Paul ^a   Mowat, Allan M C I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cell survival; IL 15; Oral tolerance; Regulatory T cell

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; CARRAGEENAN; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-15; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2;

EID: 8144223516     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01965.x     Document Type: Article

References (37)

1. Garside P, Mowat AM. Oral tolerance. Semin Immunol 2001; 13:177-85.
2. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91:6688-92.
3. + T lymphocytes. J Immunol 1989; 142:748-52.
4. + cells on the induction and maintenance of oral tolerance. Cell Immunol 1995; 163:19-29.
5. + T cells are required for the induction of oral tolerance. Int Immunol 1995; 7:501-4.
6. + T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice. J Immunol 1995; 154: 6238-45.
7. + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167:188-95.
8. + regulatory T cells by oral antigen administration. J Immunol 2001: 167:4245-53.
9. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 1998; 28:2780-90.
10. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
11. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000: 101:455-8.
12. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18:423-49.
13. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166:3008-18.
14. Cong Y, Weaver CT, Lazenby A, Elson CO. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002; 169:6112-9.
15. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA, Weiner HL. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996; 93:388-91.
16. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from Type 1 T regulatory cells. J Exp Med 2002; 196:1335-46.
17. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-10.
18. Fowler S, Powrie F. CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur J Immunol 2002; 32:2997-3006.
19. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 2001; 194:629-44.
20. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science 1994; 264:965-8.
21. Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm Res 1998; 47:285-9.
22. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-79.
23. Sprent J, Surh CD. Generation and maintenance of memory T cells. Curr Opin Immunol 2001; 13:248-54.
24. Bacchetta R, Sartirana C, Levings MK, Bordignon C, Narula S, Roncarolo MG. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 2002; 32:2237-45.
25. + T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-10.
26. + T cells that require antigen-specific activation for suppression. J Immunol 2003: 171:6431-41.
27. Wei X, Orchardson M, Gracie JA et al. The Sushi domain of soluble IL-15 receptor-α is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. J Immunol 2001; 167:277-82.
28. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998; 160:5654-60.
29. Mowat AM, Strobel S, Drummond HE, Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 1982; 45:105-13.
30. Strobel S, Mowat AM, Drummond HE, Pickering MG, Ferguson A. Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 1983; 49:451-6.
31. Weiner HL, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809-37.
32. Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 2001; 182:207-14.
33. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996; 111:1706-13.
34. Smith XG, Bolton EM, Ruchatz H, Wei X, Liew FY, Bradley JA. Selective blockade of IL-15 by soluble IL-15 receptor α-chain enhances cardiac allograft survival. J Immunol 2000; 165:3444-50.
35. + T cell response. J Exp Med 2002; 195:1463-70.
36. Miller A, Lider O, Weiner HL. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991; 174:791-8.
37. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98:70-7.